Avestar Capital, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avestar Capital, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$774,000
-34.4%
2,921
-28.4%
0.10%
-37.1%
Q3 2021$1,180,000
+8976.9%
4,082
+2451.2%
0.15%
+1787.5%
Q2 2019$13,000
+44.4%
1600.0%0.01%
+33.3%
Q1 2019$9,000
+12.5%
1600.0%0.01%
+20.0%
Q4 2018$8,0000.0%1600.0%0.01%0.0%
Q3 2018$8,000
+14.3%
1600.0%0.01%
+25.0%
Q2 2018$7,000
+40.0%
1600.0%0.00%
+33.3%
Q1 2018$5,0000.0%1600.0%0.00%
-25.0%
Q4 2017$5,0001600.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders